StonvexLoading…
StonvexStonvexStonvexCore line items from JUVF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $8.07M | $7.65M | $7.24M | $7.26M |
Operating Income | $7.03M | $4.62M | $5.50M | $3.60M |
Net Income | $5.97M | $3.92M | $4.74M | $3.10M |
EPS (Diluted) | $1.19 | $0.78 | $0.95 | $0.62 |
Total Assets | $880.47M | $866.43M | $857.96M | $862.68M |
Total Liabilities | $825.47M | $814.05M | $811.41M | $819.34M |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 5.02M | 5.02M | 5.00M | 5.00M |